Page 2 - Development Rd Dr News Today

The country’s clinical trials seeking to assess the efficacy, safety, and effect on viral clearance of anti-parasitic drug Ivermectin in asymptomatic and mild coronavirus disease (COVID-19) patients confined in isolation facilities will begin on Oct. 15, the Department of Science and Technology (DOS

The Department of Science and Technology (DOST) and Mapua University are expected to sign on Tuesday, Oct. 4, a memorandum of agreement on the implementation of the “Doctor of Philosophy (PhD) in Material Science with specialization in Nanotechnology by Research Program.” IMG_20211004_162425 DOS

The World Health Organization’s (WHO) Solidarity Vaccines Trial (SVT) has yet to start in the country, the Department of Science and Technology (DOST) has disclosed. (MANILA BULLETIN FILE PHOTO) DOST Undersecretary for Research and Development (R&D) Dr. Rowena Cristina L. Guevara, who head

The Department of Science and Technology (DOST) and University of the Philippines (UP) will inaugurate next month a new analytical facility for proteomics research that will boost the genomic research capacities of the Philippine Genome Center (PGC). Department of Science and Technology The Prot

Over 1,700 adult Filipinos have so far been enrolled in the Philippines’ yearlong “immunosurveillance” study which seeks to determine the effectiveness of coronavirus disease (COVID-19) vaccines that were granted emergency use authorization (EUA) in the country, the Department of Science and Technol

The Department of Science and Technology (DOST) is seeking more participants for its ongoing randomized controlled clinical trial on the efficacy and safety of tawa-tawa (Euphorbia hirta) extract as an adjunctive coronavirus disease (COVID-19) treatment for mild to moderate cases. Tawa-tawa (Man

The country’s eight month-long study on the use of anti-parasitic drug Ivermectin as a treatment for coronavirus disease (COVID-19) is set to begin on Sept. 15, the Department of Science and Technology (DOST) said Friday, Aug. 27. (MANILA BULLETIN FILE PHOTO) DOST Undersecretary for Research a

The Department of Science and Technology (DOST) has invested P8.4 million to determine the safety and efficacy of virgin coconut oil (VCO) as adjunctive therapy for coronavirus disease (COVID-19) patients, and to evaluate its beneficial effects for probable COVID-19 patients who are quarantined in a

There is no definite schedule yet as to when the World Health Organization’s (WHO) Solidarity Vaccine Trial (SVT) will start, the Department of Science and Technology (DOST) said. (MANILA BULLETIN FILE PHOTO) DOST Undersecretary for Research and Development (R&D) Dr. Rowena Cristina L. Guev

The second and third phases of the clinical study on the safety and efficacy of the plant-based anti-dengue drug will start in September this year, and "will be completed within a year", the Department of Science and Technology (DOST) said on Friday, Aug. 20. (MANILA BULLETIN FILE PHOTO) DOST U